First country to get a vaccine could have an economic as well as a health advantage

Investors have bet on Gilead’s remdesivir as solution to coronavirus crisis

Industry highlights bottlenecks in access to materials that are a possible Covid-19 treatment

As researchers race to develop a coronavirus vaccine, we look at efforts to ensure that the world’s poor are not left behind — and ask whether the pandemic will jolt policymakers into confronting the looming threat from antimicrobial resistance

Federal Trade Commission votes 3-2 to approve tie-up between makers of Botox and Humira

The wide variety of Covid-19 symptoms seen by doctors is confounding the scientific community

State-backed utility under pressure as it plans to invest in new coal mines

Shares in Peabody Energy and Arch Coal fall sharply after regulatory action

Group says 230 jobs will be lost at Selby site at it looks to beat 2025 fossil fuel deadline

American producers are coming under pressure on several fronts

One of the first large acquisitions to be agreed since coronavirus pandemic rocked global markets

Decline leads to a drop in wholesale prices as businesses close

Supplier says sector should be ‘back of the queue’ for additional government support

Potential cost cuts should not be used as justification for a UK telecoms tie-up

Well-capitalised businesses will have an increased advantage for the next few years

Finding love in a time of corona is tricky, converting activity into paid accounts is harder yet

How markets are beginning to stir from their coronavirus-induced slumber

Trump ally Tom Barrack’s investment group in talks with lenders over hotel and nursing home debt

Interest rate cuts and massive fiscal stimulus are expected to weigh on the greenback

First-quarter volatility deals $39bn blow to SNB as it steps up fight for Swiss franc

Mike Mackenzie’s daily analysis of what’s moving global markets

Large foreign financing requirement and small reserves leave Erdogan facing cash crunch

Analysts fear unintended consequences of central bank’s vast foreign-currency holdings

There’s a chronic paradox at the heart of stablecoin-based payment systems that will render them cost-prohibitive.

Governments should borrow more to stave off secular stagnation

Higher education should not be treated as just another business

Brazil’s Jair Bolsonaro is building the case for his own impeachment

Investors are looking to the future, but should beware of over-optimism

Economic woes go well beyond the coronavirus crisis

Countries should avoid turning to nationalism and share the burdens

Aircraft parts manufacturers pull plug in first big deal to collapse due to coronavirus pandemic

Christian Noyer believes projects available to consumers are a way off yet

Industry bodies had been lobbying for longer postponement over fears of hit to bond markets

NYSE owner did not ‘lose its mind’, says Jeffrey Sprecher

Acquisition allows group to build bigger share of the $6.6tn-a-day market

London bourse’s transformative acquisition is facing more scrutiny than expected

Watchdogs put 12-month extension on new margin requirements, citing coronavirus threat

Business being bought from Blackstone-led consortium has lost ground to Bloomberg

Filing opens door to potential sale of half of Virgin Group’s holding in space venture

John Malone shows his adroitness in deal between Liberty Global and Telefónica

Private banks are fighting to advise billionaires who want a lot for their money

Despite public anger, corporate regulation is likely to remain fragmented

In a polarised time, the broadcaster has won listeners by embracing confrontation

In 16 years of columns on business, the only constant has been disruptive innovation

Phones, TV and games constantly vie for our attention — but how much do they add to our lives?

Downfall of carmaker’s former boss sets up clash between country’s old guard and its reformists

Valuations do not reflect the risks that still lie ahead from coronavirus

Small-cap stocks underperformed large-caps throughout the bear market and rally

Remdesivir news moves markets more than economic data or Fed action

Smaller companies in ‘epic rally’ on optimism over coronavirus and policy support